{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T11:42:04Z","timestamp":1762342924340,"version":"build-2065373602"},"reference-count":28,"publisher":"Centre for Evaluation in Education and Science (CEON\/CEES)","issue":"8","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/BY\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Biochemistry"],"published-print":{"date-parts":[[2025]]},"abstract":"<jats:p>Background: This study aimed to analyse the expression changes and clinical significance of microRNA-346 (miR-346) in PCa genesis, development, and hormone resistance transition. Methods: Data of the middle-aged and elderly male patients who were treated in Tengzhou Central People's Hospital from January 2017 to December 2023 were collected. The tissues and corresponding preoperative serum of 128 patients with newly diagnosed PCa, 130 patients with benign prostatic hyperplasia (BPH), 120 patients with hormone-sensitive PCa (HSPC), 116 patients with castration-resistant PCa (CRPC), and 150 healthy males of the same age who underwent physical examination in the physical examination centre of our hospital were collected. A quantitative real-time polymerase chain reaction was used to detect the relative expression of miR-346 in the subjects' tissues and serum. GraphPad Prism statistical analysis software was utilised to analyse the expression changes of miR-346 in the occurrence and progression of PCa and its correlation with clinical and pathological features. Results: The expression of miR-346 was significantly lower in PCa patients than in BPH patients and healthy population (P &amp;lt; 0.001), while there was no difference between BPH and healthy population (P= 0.516). Tissue and serum expression were positively correlated (P&amp;lt; 0.001). miR-346 was negatively correlated with tPSA, PHI, clinical stage, and Gleason score in PCa tissue\/serum (P&amp;lt; 0.001). Serum miR-346 in CRPC patients was negatively correlated with time to transformation (r= 0 .6 5 7 5 ) and survival (r= 0.5699) (P&amp;lt; 0.001). Serum miR-346 was positively correlated with tPSA and ALP in HSPC and CRPC patients (P&amp;lt; 0.001). Conclusions: Serum miR-346 expression in hormone resistance transition in PCa is gradually increasing, making it a potential biomarker for monitoring PCa progression.<\/jats:p>","DOI":"10.5937\/jomb0-58279","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T03:20:47Z","timestamp":1747020047000},"page":"1663-1671","source":"Crossref","is-referenced-by-count":0,"title":["The role of microrna-346 in prostate cancer progression: Clinical significance and biomarker potential"],"prefix":"10.5937","volume":"44","author":[{"given":"Lei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangzhou","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3964","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Lomas DJ, Ahmed HU. All change in the prostate cancer diagnostic pathway. Nat Rev Clin Oncol 2020; 17(6): 372-81;","DOI":"10.1038\/s41571-020-0332-z"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Fletcher P De Santis M, Ippoliti S, Orecchia L, Charlesworth P Barrett T, et al. Vector Prostate Biopsy: A Novel Magnetic Resonance Imaging\/Ultrasound Image Fusion Transperineal Biopsy Technique Using Electromagnetic Needle Tracking Under Local Anaesthesia. Eur Urol 2023; 83(3): 249-56;","DOI":"10.1016\/j.eururo.2022.12.007"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Roy S, Sun Y Chi KN, Ong M, Malone S, Wallis CJD, et al. Early Prostate-Specific Antigen Response by 6 Months Is Predictive of Treatment Effect in Metastatic Hormone Sensitive Prostate Cancer: An Exploratory Analysis of the TITAN Trial. J Urol 2024; 212(5): 672-81;","DOI":"10.1097\/JU.0000000000004158"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Stella M, Russo GI, Leonardi R, Carco D, Gattuso G, Falzone L, et al. Extracellular RNAs from Whole Urine to Distinguish Prostate Cancer from Benign Prostatic Hyperplasia. Int J Mol Sci 2024; 25(18);","DOI":"10.3390\/ijms251810079"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Choi JY Park S, Shim JS, Park HJ, Kuh SU, Jeong Y, et al. Explainable artificial intelligence-driven prostate cancer screening using exosomal multi-marker based dual-gate FET biosensor. Biosens Bioelectron 2025; 267: 116773;","DOI":"10.1016\/j.bios.2024.116773"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Li J, Xu C, Lee HJ, Ren S, Zi X , Zhang Z, et al. A genomic and epigenomic atlas of prostate cancer in Asian populations. Nature 2020; 580(7801): 93-9;","DOI":"10.1038\/s41586-020-2135-x"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Balci S, Akbayir S, Bozlu M, Tamer L. Investigation of the relationship between endothelial nitric oxide synthase T786C polymorphism and PSA, PSA derivatives, and prostate cancer in the Turkish population. J Med Biochem 2023; 42(3): 357-63;","DOI":"10.5937\/jomb0-33122"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Kargutkar N, Hariharan P Nadkarni A. Dynamic interplay of microRNA in diseases and therapeutic. Clin Genet 2023; 103(3): 268-76;","DOI":"10.1111\/cge.14256"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Khan MM, Sharma V, Serajuddin M. Emerging role of miRNA in prostate cancer: A future era of diagnostic and therapeutics. Gene 2023; 888: 147761;","DOI":"10.1016\/j.gene.2023.147761"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Sidorova EA, Zhernov YV, Antsupova MA, Khadzhieva KR, Izmailova AA, Kraskevich DA, et al. The Role of Different Types of microRNA in the Pathogenesis of Breast and Prostate Cancer. Int J Mol Sci 2023; 24(3);","DOI":"10.3390\/ijms24031980"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Ho PTB, Clark IM, Le LTT MicroRNA-Based Diagnosis and Therapy. Int J Mol Sci 2022; 23(13);","DOI":"10.3390\/ijms23137167"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Fletcher CE, Deng L, Orafidiya F Yuan W, Lorentzen M, Cyran OW, et al. A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer. Mol Cancer 2022; 21(1): 82;","DOI":"10.1186\/s12943-022-01540-w"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Su ZH, Liao HH, Lu KE, Chi Z, Qiu ZQ, Jiang JM, et al. Hypoxia-responsive miR-346 promotes proliferation, migration, and invasion of renal cell carcinoma cells via targeting NDRG2. Neoplasma 2020; 67(5): 1002-11;","DOI":"10.4149\/neo_2020_190917N915"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Li X , Zhou Y, Wen P Yuan Y, Xiao Z, Shi H, et al. Tumor suppressor LHX6 upregulation contributes to the inhibitory effect of miR-346 knockdown on colorectal cancer cell growth. Environ Toxicol 2022; 37(3): 435-45;","DOI":"10.1002\/tox.23410"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Zhu J, Wang S, Zhang W, Qiu J, Shan Y, Yang D, et al. Screening key microRNAs for castration-resistant prostate cancer based on miRNA\/mRNA functional synergistic network. Oncotarget 2015; 6(41): 43819-30;","DOI":"10.18632\/oncotarget.6102"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Zhang W, Zang J, Jing X , Sun Z, Yan W, Yang D, et al. Identification of candidate miRNA biomarkers from miRNA regulatory network with application to prostate cancer. J Transl Med 2014; 12: 66;","DOI":"10.1186\/1479-5876-12-66"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Wang Q, Cai J, Cai XH, Chen L. miR-346 regulates osteogenic differentiation of human bone marrow-derived mesenchymal stem cells by targeting the Wnt\/beta-catenin pathway. PLoS One 2013; 8(9): e72266;","DOI":"10.1371\/journal.pone.0072266"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Wolter M, Werner T, Malzkorn B, Reifenberger G. Role of microRNAs Located on Chromosome Arm 10q in Malignant Gliomas. Brain Pathol 2016; 26(3): 344-58;","DOI":"10.1111\/bpa.12294"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Guo J, Lv J, Liu M, Tang H. miR-346 Up-regulates Argonaute 2 (AGO2) Protein Expression to Augment the Activity of Other MicroRNAs (miRNAs) and Contributes to Cervical Cancer Cell Malignancy. J Biol Chem 2015; 290(51): 30342-50;","DOI":"10.1074\/jbc.M115.691857"},{"key":"ref20","unstructured":"Sun JC, Wang L, Zhu XH , Shen ML. Hsa_circ_0006427 Suppresses Multiplication, Migration and Invasion of Non-Small Cell Lung Cancer Cells through miR-346\/VGLL4 Pathway. Cell J 2022; 24(5): 245-54;"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Zhang X , Yao J, Shi H, Gao B, Zhou H, Zhang Y et al. Hsa_circ_0026628 promotes the development of colorectal cancer by targeting SP1 to activate the Wnt\/ -catenin pathway. Cell Death Dis 2021; 12(9): 802;","DOI":"10.1038\/s41419-021-03794-6"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Tsai NP Lin YL, Wei LN. MicroRNA mir-346 targets the 5'-untranslated region of receptor-interacting protein 140 (RIP140) mRNA and up-regulates its protein expression. Biochem J 2009; 424(3): 411-8;","DOI":"10.1042\/BJ20090915"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Haider M, Zhang X , Coleman I, Ericson N, True LD, Lam HM, et al. Epithelial mesenchymal-like transition occurs in a subset of cells in castration resistant prostate cancer bone metastases. Clin Exp Metastasis 2016; 33(3): 239-48;","DOI":"10.1007\/s10585-015-9773-7"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Zhang Y, Xiao HQ, Wang Y, Yang ZS, Dai LJ, Xu YC. Differential expression and therapeutic efficacy of microRNA-346 in diabetic nephropathy mice. Exp Ther Med 2015; 10(1): 106-12;","DOI":"10.3892\/etm.2015.2468"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Peng D, Fu M, Wang M, Wei Y, Wei X. Targeting TGF-signal transduction for fibrosis and cancer therapy. Mol Cancer 2022; 21(1): 104;","DOI":"10.1186\/s12943-022-01569-x"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Derynck R, Turley SJ, Akhurst RJ. TG F biology in cancer progression and immunotherapy. Nat Rev Clin Oncol 2021; 18(1): 9-34;","DOI":"10.1038\/s41571-020-0403-1"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Shi X , Yang J, Deng S, Xu H, Wu D, Zeng Q, et al. TGF-signaling in the tumor metabolic microenvironment and targeted therapies. J Hematol Oncol 2022; 15(1): 135;","DOI":"10.1186\/s13045-022-01349-6"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Carascossa S, Gobinet J, Georget V, Lucas A, Badia E, Castet A, et al. Receptor-interacting protein 140 is a repressor of the androgen receptor activity. Molecular endocrinology (Baltimore, Md) 2006; 20(7): 1506-18;","DOI":"10.1210\/me.2005-0286"}],"container-title":["Journal of Medical Biochemistry"],"original-title":["Uloga mikro-RNA-346 u progresiji raka prostate - klini\u010dki zna\u010daj i potencijal kao biomarker"],"language":"en","link":[{"URL":"https:\/\/scindeks-clanci.ceon.rs\/data\/pdf\/1452-8258\/2025\/1452-82582508663W.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T11:36:12Z","timestamp":1762342572000},"score":1,"resource":{"primary":{"URL":"https:\/\/scindeks.ceon.rs\/Article.aspx?artid=1452-82582508663W"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5937\/jomb0-58279","relation":{},"ISSN":["1452-8258","1452-8266"],"issn-type":[{"type":"print","value":"1452-8258"},{"type":"electronic","value":"1452-8266"}],"subject":[],"published":{"date-parts":[[2025]]}}}